Get started
Author

Yusuf Mert Demirlenk

Observed names: Yusuf Demirlenk, Yusuf M Demirlenk, Yusuf M. Demirlenk
ORCID: 0000-0003-0904-0378
Observed ORCID: 0000-0003-0904-0378
OpenAlex ID: A5017455157
Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cells
2020 · Xiaolong Wei, Jiekun Yang, et al. · Proceedings of the National Academy of Sciences · 106
PDF
Tissue Ablation: Applications and Perspectives
2024 · Hyeongseop Keum, Enes Cevik, et al. · Advanced Materials · 33
PDF
A meta-analysis for the role of aminoglycosides and tigecyclines in combined regimens against colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections
2022 · Yusuf Mert Demirlenk, Lal Sude Gücer, et al. · European Journal of Clinical Microbiology & Infectious Diseases · 9
Prostate tissue ablation and drug delivery by an image-guided injectable ionic liquid in ex vivo and in vivo models
2024 · Yusuf M. Demirlenk, Hassan Albadawi, et al. · Science Translational Medicine · 6
PDF
Catheter‐Directed Ionic Liquid Embolic Agent for Rapid Portal Vein Embolization, Segmentectomy, and Bile Duct Ablation
2024 · Enes Cevik, Hassan Albadawi, et al. · Advanced Materials · 5
PDF
Advances and Challenges in Interventional Immuno-Oncology Locoregional Therapies
2024 · Izzet Altun, Yusuf M. Demirlenk, et al. · Journal of Vascular and Interventional Radiology · 4
Tissue Ablation: Applications and Perspectives (Adv. Mater. 32/2024)
2024 · Hyeongseop Keum, Enes Cevik, et al. · Advanced Materials · 1
Catheter‐Directed Ionic Liquid Embolic Agent for Rapid Portal Vein Embolization, Segmentectomy, and Bile Duct Ablation (Adv. Mater. 29/2024)
2024 · Enes Cevik, Hassan Albadawi, et al. · Advanced Materials · 1
PDF
Reliability study of manual and automated trabecular-iris angle measurements and 360° angle map
2019 · Duriye Damla Sevgi, Hao Wu, et al. · Investigative Ophthalmology & Visual Science
Works count: 9
Citation count: 165
H-index: 5
I10-index: 2
Year
Topic
Type